title: Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment.
abstract: BACKGROUND
  Remission, the primary goal of treatment for major depressive disorder (MDD), is the absence of significant signs or symptoms and the return to a state of normal functioning. A recent study found that the level of brain-derived neurotrophic factor (BDNF) increased after antidepressant treatment in remitted patients. This study evaluated serum BDNF levels in MDD patients with chronic maintenance treatment, and compared these between remission and nonremission groups.
  
  
  METHODS
  Serum BDNF levels were measured in 34 MDD patients and 35 healthy controls. The severity of depression was measured using the Hamilton Depression Rating Scale (Ham-D). The MDD patients were divided into remission and nonremission groups according to a cutoff total Ham-D score of either ≤7 or ≤6.
  
  
  RESULTS
  Serum BDNF levels differed significantly between the remission, nonremission, and healthy control groups (P<0.05). The Bonferroni post hoc test confirmed that serum BDNF levels were significantly lower in the nonremission group than in the healthy-control group (P<0.05), but did not differ significantly between the remission and healthy-control groups.
  
  
  CONCLUSIONS
  This study included a small sample, and measured serum BDNF levels in the MDD patients at only one point during the maintenance treatment.
  
  
  CONCLUSIONS
  This study found that serum BDNF levels during maintenance treatment were lower in MDD patients with failure to achieve remission than in controls, while the remitted subjects had normalized serum BDNF levels. A lower level of serum BDNF during maintenance treatment is associated with failure to achieve remission in patients with major depression. Moreover, serum BDNF levels after chronic antidepressant treatment can be used as a biological marker for detecting nonremission.
authors.affiliation: Department of Psychiatry, Gangnam Eulji Hospital, Eulji University, Seoul, South Korea.
authors.forename: Bun-Hee
authors.initials: BH
authors.lastname: Lee
authors.affiliation: Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
authors.forename: Young-Min
authors.initials: YM
authors.lastname: Park
authors.affiliation: Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
authors.forename: Tae Hyun
authors.initials: TH
authors.lastname: Um
authors.affiliation: Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
authors.forename: Sollip
authors.initials: S
authors.lastname: Kim
keywords: brain-derived neurotrophic factor; major depression; remission
references.citation: Curr Opin Pharmacol. 2007 Feb;7(1):18-21
references.pmid: 17049922
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1034-7
references.pmid: 17459550
references.citation: PLoS One. 2012;7(6):e39212
references.pmid: 22761741
references.citation: Hippocampus. 2006;16(3):239-49
references.pmid: 16425236
references.citation: Arch Gen Psychiatry. 1991 Sep;48(9):851-5
references.pmid: 1929776
references.citation: Psychol Med. 2010 Jan;40(1):41-50
references.pmid: 19460188
references.citation: Mol Psychiatry. 2014 Jul;19(7):791-800
references.pmid: 23958957
references.citation: Biol Psychiatry. 2008 Sep 15;64(6):527-32
references.pmid: 18571629
references.citation: Psychiatr Danub. 2011 Dec;23(4):363-9
references.pmid: 22075737
references.citation: J Clin Psychiatry. 2001;62 Suppl 16:5-9
references.pmid: 11480882
references.citation: Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80
references.pmid: 18752720
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):415-20
references.pmid: 20732374
references.citation: J Psychiatr Res. 2010 Nov;44(15):1063-8
references.pmid: 20447651
references.citation: Bipolar Disord. 2008 Feb;10(1):95-100
references.pmid: 18199246
references.citation: J Affect Disord. 2007 Aug;101(1-3):239-44
references.pmid: 17173978
references.citation: Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):381-6
references.pmid: 15809771
references.citation: J Clin Psychol. 2006 Jan;62(1):123-46
references.pmid: 16287149
references.citation: Neuropsychobiology. 2008;57(4):194-9
references.pmid: 18679038
references.citation: World J Biol Psychiatry. 2010 Sep;11(6):763-73
references.pmid: 20334574
references.citation: J Affect Disord. 2003 Feb;73(3):237-44
references.pmid: 12547292
references.citation: Neuropsychobiology. 2010;62(4):207-12
references.pmid: 20714169
references.citation: Mol Psychiatry. 2011 Nov;16(11):1088-95
references.pmid: 20856249